[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: دوره 13، شماره 1 - ( 3-1398 ) ::
جلد 13 شماره 1 صفحات 23-16 برگشت به فهرست نسخه ها
The Indinavir Derivate as a Novel Pharmacophore for Treatment of HTLV-1 Viral Infections
چکیده:   (1525 مشاهده)
Background and Aims: Human T-lymphotropic virus type 1 (HTLV-1), is as a type C retrovirus, which was first isolated from a patient with Adult T-cell leukemia/lymphoma (ATLL). Approximately 10-20 million people are infected by HTLV-1 virus worldwide, but only 5-10% of them develop clinical manifestations such as Acute-T lymphoma (ATL), HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), uveitis, and infective dermatitis. Indinavir was the first protease inhibitor used for treating HIV-1. It has some activity on HTLV-1, but it is not fully able to inhibit the HTLV-1 protease. Nowadays, design and construction of novel pharmacophore compounds can serve as an appropriate replacement for Indinavir. 
Materials and Methods: In the present research, we used bioinformatics studies, to evaluate the potential role of four novel pharmacophres with inhibitory function on HTLV-1 protease, so called KMI pharmacophores (Keikha Modified Indinavir).
Results: After a detailed structural analysis of each of them, it seems all four designed phamacophores, (especially KMI-3) could be more effective on HTLV-1 protease than Indinavir.
Conclusions: According to exact in silico evaluations of each four pharmacophores, KMI-3 demonstrated a potential for its use on treatment of HTLV-1 infections. 
متن کامل [PDF 952 kb]   (1211 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: عمومى
دریافت: 1398/8/9 | پذیرش: 1399/1/12 | انتشار: 1399/1/12
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

youssefi M, ghazvini K, Brites C, Karbalaei M, keikha M. The Indinavir Derivate as a Novel Pharmacophore for Treatment of HTLV-1 Viral Infections. Iran J Virol 2019; 13 (1) :16-23
URL: http://journal.isv.org.ir/article-1-366-fa.html

The Indinavir Derivate as a Novel Pharmacophore for Treatment of HTLV-1 Viral Infections. مجله ویروس شناسی ایران 1398; 13 (1) :23-16

URL: http://journal.isv.org.ir/article-1-366-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 13، شماره 1 - ( 3-1398 ) برگشت به فهرست نسخه ها
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4540